Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00544700 | Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer | terminated | Phase 3 | 265 | Swiss Cancer InstituteOTHER | 1 | Feb 20, 2020 | clinicaltrials |
| NCT03035279 | A Study of SC-006 and in Combination With ABBV-181 in Subjects With Advanced Colorectal Cancer | terminated | Phase 1 | 29 | AbbVieINDUSTRY | 1 | Feb 20, 2020 | clinicaltrials |
| NCT02687009 |
| A Study of Niclosamide in Patients With Resectable Colon Cancer |
| terminated |
| Phase 1 |
| 1 |
| Michael Morse, MDOTHER |
| 1 |
| Feb 19, 2020 |
| clinicaltrials |
| NCT01057017 | First-Line FOLFOX-Bevacizumab for Advanced Colorectal Cancer With Wild-Type Ras | terminated | Phase 2 | 5 | Brown UniversityOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT01669720 | Adjuvant Aflibercept for Metastatic Colorectal Cancer(C261) | terminated | Phase 2 | 10 | Brown UniversityOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT02425683 | Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX | terminated | Phase 2 | 24 | US Oncology ResearchINDUSTRY | 1 | Feb 10, 2020 | clinicaltrials |
| NCT02576665 | A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) | terminated | Phase 1 | 21 | Tocagen Inc.INDUSTRY | 1 | Feb 7, 2020 | clinicaltrials |
| NCT02809846 | Quell Opioid Reduction and Pain Relief in Patients With Cancer | terminated | N/A | 33 | Scripps Translational Science InstituteOTHER | 1 | Jan 21, 2020 | clinicaltrials |
| NCT01532804 | 2nd-line Treatment of Metastatic Colorectal Cancer(BEVATOMOX) | terminated | Phase 2 | 83 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Dec 26, 2019 | clinicaltrials |
| NCT02328664 | SCar-biopsies After Malignant Colorectal Polypectomy of Uncertain RAdicality(SCAPURA) | terminated | N/A | 246 | Dr. Frank ter Borg MD PhDOTHER | 1 | Dec 17, 2019 | clinicaltrials |
| NCT00923052 | The Natural History of Solid Organ Cancer Stem Cells (SOCSC) | terminated | — | 190 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT00580073 | Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum | terminated | Phase 2 | 6 | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT01902823 | Effect of Cancer Nurse Navigators on Patient Outcomes | terminated | Phase 2 / Phase 3 | 16 | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT01881932 | Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232) | terminated | N/A | 19 | University of Maryland, BaltimoreOTHER | 1 | Nov 7, 2019 | clinicaltrials |
| NCT02290574 | Efficacy of NeoThermo-Radio-chemotherapy for LA Rectal Cancer Before Laparoscopic TME: Prospective Phase II Trial(NEOTREAT) | terminated | N/A | 14 | Samsung Medical CenterOTHER | 1 | Nov 1, 2019 | clinicaltrials |
| NCT02318901 | Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer(PembroMab) | terminated | Phase 1 / Phase 2 | 16 | Western Regional Medical CenterOTHER | 1 | Oct 21, 2019 | clinicaltrials |
| NCT00078897 | Selenium for Prevention of Adenomatous Colorectal Polyps | terminated | Phase 3 | 1,621 | University of ArizonaOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT03682133 | PreColo Practice Variation | terminated | — | 20 | Radboud University Medical CenterOTHER | 1 | Sep 13, 2019 | clinicaltrials |
| NCT00397878 | AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer | terminated | Phase 2 | 10 | National Cancer Institute (NCI)NIH | 1 | Aug 20, 2019 | clinicaltrials |
| NCT02233595 | Evaluation of Rectal Cancer Treatment Response Using PET/MRI(Rectal PET/MRI) | terminated | — | 7 | University of California, San FranciscoOTHER | 1 | Aug 13, 2019 | clinicaltrials |
| NCT03204201 | Validation of ICG to Identify the Urethra During Rectal Surgery | terminated | Phase 1 / Phase 2 | 5 | Oxford University Hospitals NHS TrustOTHER | 1 | Aug 13, 2019 | clinicaltrials |
| NCT03204994 | Fluorescence Targeted Pelvic Lymph Node Mapping | terminated | Phase 1 / Phase 2 | 1 | Oxford University Hospitals NHS TrustOTHER | 1 | Aug 13, 2019 | clinicaltrials |
| NCT00126867 | Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment | terminated | — | 29 | AHS Cancer Control AlbertaOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT02585271 | Transanal Decompression Tube Versus Stent for Acute Malignant Left-sided Colonic and Rectal Obstruction | terminated | N/A | 8 | Xuzhou Central HospitalOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT02005614 | A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection | terminated | N/A | 39 | Yale UniversityOTHER | 1 | Jul 1, 2019 | clinicaltrials |
| NCT03431311 | T Cell Receptor Based Therapy of Metastatic Colorectal Cancer(TCR-CRC-001) | terminated | Phase 1 / Phase 2 | 1 | Oslo University HospitalOTHER | 1 | Jun 13, 2019 | clinicaltrials |
| NCT00777192 | Longitudinal Study of Symptoms in Colorectal Cancer | terminated | — | 509 | M.D. Anderson Cancer CenterOTHER | 1 | May 29, 2019 | clinicaltrials |
| NCT03634202 | Study of Radiation Therapy in Combination With Xeloda, for Initially Metastatic, Low and Middle Rectal Cancer(DESIR) | terminated | N/A | 9 | Institut Cancerologie de l'OuestOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT03645876 | SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer | terminated | Phase 2 | 12 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | May 10, 2019 | clinicaltrials |
| NCT03070574 | Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome(MesaCAPP) | terminated | Phase 2 | 8 | Christoph GascheOTHER | 6 | Apr 18, 2019 | clinicaltrials |
| NCT01479465 | Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma | terminated | Phase 2 | 266 | Gilead SciencesINDUSTRY | 7 | Apr 17, 2019 | clinicaltrials |
| NCT01879943 | Capsule Versus Conventional Colonoscopy in Patient Following Colorectal Surgery | terminated | N/A | 37 | IHU StrasbourgOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT00423345 | Colon Investigation - Factors Determining Choice of Procedure | terminated | — | 750 | Sykehuset TelemarkOTHER_GOV | 1 | Apr 8, 2019 | clinicaltrials |
| NCT02139475 | Factors Influencing Quality of Bowel Cleansing for Colonoscopy in Patients With Colorectal Cancer Surgery; Prospective Observational Study | terminated | — | 273 | Yonsei UniversityOTHER | 1 | Mar 29, 2019 | clinicaltrials |
| NCT02568046 | Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients | terminated | Phase 1 / Phase 2 | 10 | Symphogen A/SINDUSTRY | 2 | Mar 26, 2019 | clinicaltrials |
| NCT03455751 | Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery(PPaM) | terminated | N/A | 10 | The Cleveland ClinicOTHER | 1 | Mar 18, 2019 | clinicaltrials |
| NCT00264979 | Evaluation of 2 Resection Strategies of Synchronous Colorectal Cancer Metastases(METASYNC) | terminated | N/A | 105 | Rennes University HospitalOTHER | 1 | Mar 11, 2019 | clinicaltrials |
| NCT01445054 | 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer | terminated | Early Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Mar 11, 2019 | clinicaltrials |
| NCT02883790 | Effects of Somnage® in the Management on Sleep and Mood in Cancer Patients | terminated | N/A | 3 | Helsinn Healthcare SAINDUSTRY | 1 | Feb 22, 2019 | clinicaltrials |
| NCT02605044 | Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer | terminated | Phase 3 | 123 | AB ScienceINDUSTRY | 3 | Feb 11, 2019 | clinicaltrials |
| NCT01871311 | A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors | terminated | Phase 1 | 15 | Georgetown UniversityOTHER | 1 | Feb 8, 2019 | clinicaltrials |
| NCT01458925 | Feasibility of Check-Cap's P1 Capsule System Screening | terminated | N/A | 143 | Check-Cap Ltd.INDUSTRY | 1 | Feb 4, 2019 | clinicaltrials |
| NCT02402036 | A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer | terminated | Phase 2 | 10 | Georgetown UniversityOTHER | 1 | Jan 29, 2019 | clinicaltrials |
| NCT02205398 | Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy | terminated | Phase 1 | 13 | Novartis PharmaceuticalsINDUSTRY | 7 | Jan 22, 2019 | clinicaltrials |
| NCT02726334 | A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer. | terminated | Phase 1 | 22 | Bionomics LimitedINDUSTRY | 1 | Jan 16, 2019 | clinicaltrials |
| NCT00611858 | Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer | terminated | Phase 2 | 13 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 8, 2019 | clinicaltrials |
| NCT01925274 | A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer | terminated | Phase 2 | 19 | PfizerINDUSTRY | 4 | Jan 8, 2019 | clinicaltrials |
| NCT01523639 | A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis(G-LUCAS) | terminated | Phase 2 | 8 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 19, 2018 | clinicaltrials |
| NCT00267787 | Molecular Genetic and Pathological Studies of Anal Tumors | terminated | — | 7 | Stanford UniversityOTHER | 1 | Dec 10, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Feb 20, 2020source: clinicaltrials